IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 11, 5723-5731
Abstract
Purpose: Cancer stem cells (CSCs) are a small population of cancer cells located within a tumor that are highly tumorigenic, capable of tumor initiation, and resistant to cancer therapies. We identified the potential genes involved in regulating stemness properties and investigated the mechanisms in small-cell lung cancer (SCLC). Materials and methods: Whole transcriptome sequencing technology was used to screen the potential genes involved in regulating stemness properties from SCLC-SCs (uPAR+) and differentiated cells (uPAR-) in the H446 cell line. The selected genes were validated by quantitative reverse transcription PCR and ELISAs. The effect of IL-8 on stemness of sphere-forming cells was determined through tumor sphere formation, wound healing migration, and in vivo tumorigenesis assays. Results: In our study, uPAR+ and uPAR- cells showed different gene expression profiles. IL-8 was upregulated in SCLC sphere-forming cells. Blocking IL-8 expression with siRNA led to loss of stemness, including the self-renewal capability, migration, expression of stemness-related genes, and in vivo tumorigenicity, in sphere-forming cells. Consistently, exogenously added IL-8 enhanced stemness properties in parental cells. Conclusion: IL-8 was upregulated in SCLC sphere-forming cells, and critical for the acquisition and/or maintenance of the stemness features in the SCLC cell line H446. Our results suggest that blocking IL-8 signaling may provide a novel therapeutic approach for targeting SCLC-SCs and improve treatment and outcomes in SCLC.Keywords
This publication has 29 references indexed in Scilit:
- Benzopyrene promotes lung cancer A549 cell migration and invasion through up-regulating cytokine IL8 and chemokines CCL2 and CCL3 expressionExperimental Biology and Medicine, 2016
- IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancerOncotarget, 2015
- Targeting IL-8 signalling to inhibit breast cancer stem cell activityExpert Opinion on Therapeutic Targets, 2013
- Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cellsBreast Cancer Research, 2013
- Treatment of small cell lung cancerCritical Reviews in Oncology/Hematology, 2004
- Multiple control of interleukin-8 gene expressionJournal of Leukocyte Biology, 2002
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.The Journal of Immunology, 1987
- [Current perspectives in the management of small cell lung cancer].1985